Treosulfan Completed Phase 2 Trials for Myelodysplastic Syndrome / Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00491634Treosulfan-based Conditioning for Transplantation in AML/MDS